APA

Amlot P. L., Stone M. J., Cunningham D., Fay J., Newman J., Collins R., May R., McCarthy M., Richardson J. & Ghetie V. (19931126). A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. : Blood.

Chicago

Amlot P L, Stone M J, Cunningham D, Fay J, Newman J, Collins R, May R, McCarthy M, Richardson J and Ghetie V. 19931126. A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. : Blood.

Harvard

Amlot P. L., Stone M. J., Cunningham D., Fay J., Newman J., Collins R., May R., McCarthy M., Richardson J. and Ghetie V. (19931126). A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. : Blood.

MLA

Amlot P L, Stone M J, Cunningham D, Fay J, Newman J, Collins R, May R, McCarthy M, Richardson J and Ghetie V. A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. : Blood. 19931126.